Array.
St George's, University of London, London, UK.
Acta Biomed. 2020 Jul 13;91(4):ahead of print. doi: 10.23750/abm.v91i4.9828.
COVID-19 has impacted the primary management of cardiac conditions, decreasing the number of interventions of coronary diseases. Elective coronary treatments and imaging have been largely cancelled across the world to make way for increased resources for COVID-19 patients. The impact on these cardiac patients during these times may be drastic. The number of hospital patients presenting with coronary symptoms during the outbreak has also decreased internationally. In this review, we discuss how COVID-19 has affected primary cardiac intervention globally and our service, possible reasons why, and how morbidity rates can be reduced by introducing scoring systems and telemedicine.
COVID-19 对心脏疾病的主要治疗产生了影响，减少了冠心病的介入治疗数量。为了给 COVID-19 患者腾出更多资源，世界各地的择期冠状动脉治疗和影像学检查已基本取消。在此期间，这些心脏病患者可能会受到严重影响。在疫情期间，国际上因冠状动脉症状而住院的患者人数也有所减少。在这篇综述中，我们讨论了 COVID-19 如何对全球主要心脏介入治疗产生影响，以及我们的服务、可能的原因，以及如何通过引入评分系统和远程医疗来降低发病率。
